文献速递肺外科

全肺切除术后第二原发肺癌的肺切除术:基于人群的研究

Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
PubMed 文献 · Ann Thorac Surg · 2017-07-12

基于SEER数据库(1988-2012)分析全肺切除术后对侧非小细胞肺癌(NSCLC)的手术治疗模式与生存。13,370例全肺切除患者中402例(3.0%)发生对侧NSCLC,170例符合筛选标准,63例(37.1%)接受手术切除(亚肺叶56例,肺叶7例)。亚肺叶切除中位总生存42个月优于肺叶切除18个月,1年和3年生存率分别为79%和54%。

要点

  • 全肺切除术后对侧NSCLC发生率3.0%,仅37.1%符合条件者接受手术。
  • I/II期且肿瘤≤2cm者更可能接受手术,亚肺叶切除为主。
  • 亚肺叶切除中位生存42个月优于肺叶切除18个月。

核心结论

  • 对选择性小肿瘤(≤2cm)和早期(I/II期)患者,全肺切除术后可安全行亚肺叶切除。
  • 尽管围手术期死亡率显著,但1年和3年生存率尚可,可能支持再次手术。

研究设计与样本

  • 基于SEER数据库(1988-2012)的回顾性人群研究。
  • 纳入全肺切除后发生对侧NSCLC的患者,共170例符合标准。

主要发现

  • 13,370例全肺切除患者中402例(3.0%)发生对侧NSCLC。
  • 63例(37.1%)接受手术,其中亚肺叶切除56例,肺叶切除7例。
  • 术后1个月和3个月死亡率分别为11.1%(亚肺叶10.7%,肺叶14.3%)和12.7%(亚肺叶12.5%,肺叶14.3%)。
  • 术后1年和3年总生存率分别为79%和54%。
  • 亚肺叶切除中位总生存42个月,肺叶切除18个月;异时性肿瘤切除后中位生存40个月,转移性肿瘤28个月。

关键数值与推荐

  • I/II期且肿瘤大小≤2cm的患者更可能接受手术。
  • 亚肺叶切除中位总生存42个月,肺叶切除18个月。

临床怎么用

  • 对于全肺切除术后对侧早期小NSCLC,可考虑亚肺叶切除,但需充分评估围手术期风险。

局限性

  • 回顾性研究,存在选择偏倚。
  • SEER数据库缺乏详细的手术和围手术期信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary resection for a second lung cancer after pneumonectomy is generally considered to be at prohibitive risk. Using a population-based database, we examined treatment patterns and survival in patients who underwent pulmonary resection after pneumonectomy for lung cancer. METHODS: We queried the Surveillance, Epidemiology, and End Results (SEER) database (1988-2012) to identify patients who underwent pneumonectomy and subsequently experienced contralateral non-small cell lung cancer (NSCLC). Multivariate logistic regression was performed to identify the factors associated with the receipt of surgical resection. Survival was estimated with the Kaplan-Meier method. RESULTS: Of 13,370 patients who underwent pneumonectomy, 402 (3.0%) experienced subsequent contralateral NSCLC, and 170 (42%) met the selection criteria. Surgical resection was performed in 63 (37.1%) cases (sublobar n = 56, lobectomy, n = 7). Patients with stage I/II disease and tumor size 2 cm or smaller were more likely to undergo surgical procedures. The 1-month and 3-month mortality after resection was 11.1% (sublobar resection 10.7%, lobectomy 14.3%) and 12.7% (sublobar 12.5%, lobectomy 14.3%), respectively. The overall 1-year and 3-year survival after surgical resection was 79% and 54%, respectively. The patients who underwent sublobar resection had higher median overall survival than did those who underwent lobectomy (42 vs 18 months). Similarly, median survival after resection for metachronous tumors was higher than after resection for metastatic cancers (40 vs 28 months). CONCLUSIONS: On the basis of our analysis of the SEER database, sublobar resection can be performed in selected patients with small tumors (≤2 cm) and early-stage disease (stage I/II). Although perioperative mortality is significant, the favorable 1-year and 3-year survival may justify the role of an additional procedure on the single lung.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ayub A, Rehmani SS, Al-Ayoubi AM, et al. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study. Ann Thorac Surg. 2017. PMID: 28709663. doi:10.1016/j.athoracsur.2017.04.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。